FreeStyle Libre allows patients to monitor glucose without the need for pricking
News
FDA grants fast-track designation for Shire’s lung drug
SHP607 targets chronic lung disease in premature infants
ESMO news – 13 September
New results from BMS and Pfizer
Humira gets EC approval for anterior uveitis
Humira is now the only EU biologic treatment option for children with the disease
Conference round-up: ERS and ESMO
News from the European Respiratory Society and European Society for Medical Oncology congresses
Prix Galien opens for entries with new award
2018 Awards will include an new category for Medical Technology, alongside accolades for Innovative Products, Orphan Products and Real World Evidence.
SMC accepts 4 new medicines
Approvals for Lilly, BMS, TESARO and Alan Pharmaceuticals
New migraine results for both Allergan and Novartis
New data presented for Allergan’s Botox and Novartis’ erenumab
Merck to co-lead Big Data alliance
Firm will partner with Project Data Sphere
ESMO roundup – 11 September
Renal cell carcinoma results dominate
Roche blood test can accurately predict immunotherapy efficacy
Test measures tumour mutations to show which patients respond best to certain immunotherapies
Lilly to cut 3,500 jobs in cost-cutting measure
Company expects to save $500 million annually
GSK makes T-cell move
Firm exercises option to exclusively license rights for Adaptimmune’s NY-ESO SPEAR
NHS negligence bill set to double
Cost of clinical negligence claims is rising at a faster rate year-on-year than NHS funding
3 UK wins in Practice to Policy Health Awards
Wins for Cambridge University Hospitals, The PBC Foundation and Nottingham University Hospitals
